Foralumab Nasal Spray Shown to Ease Fatigue in Nonactive SPMS

Jan 10, 2024

Six of eight patients with nonactive secondary progressive multiple sclerosis (SPMS) being treated with foralumab nasal spray — all part of an intermediate-size expanded access program (EAP) allowing the therapy’s use — have experienced reductions in their fatigue...

Monte Rosa Plans to Begin Phase 1 Trial of MRT-6160 in Mid-2024

Jan 10, 2024

Monte Rosa Therapeutics is planning to initiate a Phase 1 clinical trial to test MRT-6160, its investigational therapy for multiple sclerosis (MS) and other autoimmune diseases, by mid-2024. The trial will follow the submission of an an investigational new drug (IND)...

Love and MS

Jan 9, 2024

Let’s be honest, it’s very easy to admit that we love our significant others, but we may not always like them. That is naturally going to happen when you literally spend the rest of your life with someone. When the person you love has MS, things may not always make...

Join Neuro Outlook’s Warrior Walk Group

Nov 8, 2023

We understand that mobility issues can present unique obstacles when it comes to participating in physical activities, and we want to create a welcoming and inclusive space where everyone can enjoy the benefits of walking, socializing, and feeling like they are in a...